Regina Hodits
Managing Director
Works at Angelini Ventures
Investor profile | Builders Republic
About
Managing Director at Angelini Ventures in Munich, Regina Hodits invests in Series A and Series B with check sizes ranging from €0.3 to €5 million, focusing on a specialized thesis in life sciences and biotech. She spent 15 years as Managing Partner at Wellington Partners Life Sciences, after being a General Partner at Atlas Venture and an Investment Manager at Apax Partners, accumulating over 25 years in venture capital. Her track record includes notable investments in Rigontec, Bicycle Therapeutics, and Jenavalve. She serves on the board of the BioInnovation Institute and has served as an External Director on the board of GSK. She holds a PhD in biochemistry from the Technische Universität Wien.
Profile
- Role
- Managing Director
- Fund
- Angelini Ventures
- Nationality
- German